Valuation : Sanofi

Market Cap 92.08B 107B 86.74B 79.03B 148B 10,083B 149B 1,027B 399B 5,155B 401B 392B 16,935B P/E 2026 *
12.3x
P/E 2027 * 10.7x
Enterprise Value 104B 120B 97.54B 88.87B 166B 11,338B 167B 1,155B 448B 5,797B 451B 441B 19,042B EV / Sales 2026 *
2.17x
EV / Sales 2027 * 1.98x
Free-Float
88.34%
Yield 2026 *
5.54%
Yield 2027 * 5.85%
1 day-7.67%
1 week+5.12%
Current month+8.47%
1 month+12.70%
3 months+12.07%
6 months-0.47%
Current year-0.77%
1 week 44.22
Extreme 44.2236
48.28
1 month 42.48
Extreme 42.48
48.28
Current year 40.8
Extreme 40.8
49.57
1 year 40.8
Extreme 40.8
52.65
3 years 40.8
Extreme 40.8
60.08
5 years 36.99
Extreme 36.988
60.08
10 years 36.99
Extreme 36.988
60.08
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Tech/Sci/R&D Officer - 01/09/2026
Director TitleAgeSince
Director/Board Member 61 30/04/2019
Director/Board Member 57 28/04/2020
Director/Board Member 65 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-3.44%+5.12% - - 107B
+0.22%-1.93%+58.65%+108.96% 1,034B
+1.17%+1.59%+54.05%+70.72% 654B
+0.33%-0.84%+23.02%+78.45% 459B
+0.49%-5.19%+33.28%+35.53% 343B
+0.27%+3.26%+29.76%+47.50% 307B
+0.12%-2.11%+0.60%+12.03% 251B
+0.52%+0.03%+53.52%+73.41% 237B
+2.64%-1.08%-15.85%-53.97% 202B
-0.17%+1.14%+32.89%+99.27% 186B
Average -0.20%-2.88%+29.99%+52.43% 407.95B
Weighted average by Cap. +0.33%-3.31%+38.90%+67.99%

Financials

2026 *2027 *
Net sales 47.68B 55.27B 44.92B 40.93B 76.5B 5,221B 77.07B 532B 206B 2,669B 208B 203B 8,769B 50.81B 58.9B 47.86B 43.61B 81.51B 5,564B 82.12B 567B 220B 2,844B 221B 216B 9,344B
Net income 7.91B 9.17B 7.45B 6.79B 12.69B 866B 12.79B 88.23B 34.24B 443B 34.43B 33.68B 1,455B 9.24B 10.71B 8.71B 7.93B 14.83B 1,012B 14.94B 103B 40.01B 517B 40.24B 39.36B 1,700B
Net Debt 11.46B 13.28B 10.79B 9.83B 18.38B 1,255B 18.52B 128B 49.59B 641B 49.87B 48.78B 2,107B 8.3B 9.63B 7.82B 7.13B 13.32B 909B 13.42B 92.61B 35.94B 465B 36.14B 35.35B 1,527B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
01/09/26 $44.46 -0.11% 425
31/08/26 $44.51 -0.51% 302
28/08/26 $44.74 -0.40% 3,779
27/08/26 $44.92 -1.23% 1,423
26/08/26 $45.48 -0.98% 866
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
76.86EUR
Average target price
94.28EUR
Spread / Average Target
+22.66%

Quarterly revenue - Rate of surprise